Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
BELANTAMAB MAFODOTIN-BLMF 70 MG INTRAVENOUS SOLUTION (CDM RX-219415) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 29, 2026 , from http://ppman.hank.ai/transparency/procedure/RX-219415/by-state?code_type=CDM
“BELANTAMAB MAFODOTIN-BLMF 70 MG INTRAVENOUS SOLUTION (CDM RX-219415) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/RX-219415/by-state?code_type=CDM. Accessed
October 29, 2026 .
“BELANTAMAB MAFODOTIN-BLMF 70 MG INTRAVENOUS SOLUTION (CDM RX-219415) by State,” HANK Price Transparency ,
accessed October 29, 2026 ,
http://ppman.hank.ai/transparency/procedure/RX-219415/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
RX-219415 — Belantamab Mafodotin-blmf 70 Mg Intravenous Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$63,916
National median
$63,916 – $64,589
IQR (p25 – p75)
15
hospitals filing
3
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for RX-219415 (CDM), with interquartile range
State Median p25 p75
FL $80,960 $55,772 $85,457
WI $64,253 $63,916 $65,262
MN $63,916 $62,571 $63,916